Copyright © 1990 by the European Society of Cardiology.
© 1990 The European Society of Cardiology
Is the atherogenicity of Lp(a) caused by its reactivity with proteoglycans?
* Institute of Medical Biochemistry, University of Graz A-8010 Graz, Austria
Second Dept. Pathology, Semmelweis Medical University Budapest, Hungary
Address for correspondence Gert M. Kostner, Medical Biochemistry, Harrachgasse 21, A-8010 Graz, Austria
Apo B-containing lipoproteins from human plasma were studied for their ability to form complexes with glycosaminoglycans (GAG) and proteoglycans (PG) in the presence of Ca++ and Mg++ ions. We studied low density lipoproteins (LDL), Lp(a) as well as Lpa-, a particle generated from Lp(a) by removing the specific antigen (apo-a). The strongest reactivity with all apo B-containing lipoproteins was found with PG, followed by GAG isolated from human aorta, and by chondroitin - 6-sulphate. Lp(a), on the other hand, formed complexes with the highest glycan: lipoprotein ratio using all three complexing agents. Treatment of Lp(a) with neuraminidase did not change the reactivity. The reactivity of Lpa-, on the other hand, was between that of Lp(a) and LDL. Lipoprotein glycan complexes were incubated with mouse peritoneal macrophages. This caused cholesterol ester accumulation and foam cell formation. The amount of cholesterol ester formed correlated highly significantly with the reactivity of a given lipoprotein with different glycans.
Sera obtained from patients suffering from myocardial infarction (MI) were incubated with LDL and Lp(a) and the reisolated lipoproteins were also incubated with macrophages. Lipoproteins reisolated from MI plasma caused foam cell formation with MPM to a greater extent than reisolated material incubated with normal plasma. The highest cholesteryl ester accumulation was found when Lp(a) reisolated from MI plasma was incubated with MPM.
These results may at least partly explain the higher atherogenicity of Lp(a) in comparison with LDL.
Key Words: Glycosaminoglycans • macrophages • foam cells • chondroitin-6-sulphate
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Simionescu Implications of Early Structural-Functional Changes in the Endothelium for Vascular Disease Arterioscler Thromb Vasc Biol, February 1, 2007; 27(2): 266 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chironi, A. Simon, N. Denarie, B. Vedie, V. Sene, J.-l. Megnien, and J. Levenson Determinants of Progression of Coronary Artery Calcifications in Asymptomatic Men at High Cardiovascular Risk Angiology, November 1, 2002; 53(6): 677 - 683. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Sonmez, S. Suer, T. Ulutin, E. Kokoglu, and N. Ucisik The Relationship of Various Factors in the Pathogenesis of Atherosclerosis Clinical and Applied Thrombosis/Hemostasis, April 1, 1998; 4(2): 105 - 110. [Abstract] [PDF]
|
|